硬化注射治疗血管瘤专家共识

2021-08-25 中国医师协会介入医师分会妇儿介入专委会 中华介入放射学电子杂志

婴幼儿血管瘤是最常见的婴幼儿良性肿瘤,可能会影响外观、患儿生活质量甚至引起功能障碍。现阶段血管瘤的治疗方法非常多,其中硬化注射治疗是很常用的治疗方法。

中文标题:

硬化注射治疗血管瘤专家共识

发布日期:

2021-08-25

简要介绍:

婴幼儿血管瘤是最常见的婴幼儿良性肿瘤,可能会影响外观、患儿生活质量甚至引起功能障碍。现阶段血管瘤的治疗方法非常多,其中硬化注射治疗是很常用的治疗方法。中国医师协会介入医师分会妇儿介入专委会组织从事临床治疗的介入放射科、血管瘤科、皮肤科、小儿外科及整形科等相关专业的专家,根据硬化剂注射疗法的国内外现状,参考国内外相关资料,就血管瘤的基本概念、诊断和治疗原则等制定《硬化注射治疗血管瘤专家共识(2021版)》,旨在提供一个硬化注射治疗血管瘤的诊疗规范。 

相关资料下载:
[AttachmentFileName(sort=1, fileName=硬化注射治疗血管瘤专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=5016a1c0022359f8, title=硬化注射治疗血管瘤专家共识, enTitle=, guiderFrom=中华介入放射学电子杂志, authorId=0, author=, summary=婴幼儿血管瘤是最常见的婴幼儿良性肿瘤,可能会影响外观、患儿生活质量甚至引起功能障碍。现阶段血管瘤的治疗方法非常多,其中硬化注射治疗是很常用的治疗方法。, cover=https://img.medsci.cn/20211022/1634913974714_1608702.jpg, journalId=0, articlesId=null, associationId=2042, associationName=中国医师协会介入医师分会妇儿介入专委会, associationIntro=中国医师协会介入医师分会妇儿介入专委会, copyright=0, guiderPublishedTime=Wed Aug 25 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">婴幼儿血管瘤是最常见的婴幼儿良性肿瘤,可能会影响外观、患儿生活质量甚至引起功能障碍。现阶段血管瘤的治疗方法非常多,其中硬化注射治疗是很常用的治疗方法。中国医师协会介入医师分会妇儿介入专委会组织从事临床治疗的介入放射科、血管瘤科、皮肤科、小儿外科及整形科等相关专业的专家,根据硬化剂注射疗法的国内外现状,参考国内外相关资料,就血管瘤的基本概念、诊断和治疗原则等制定《硬化注射治疗血管瘤专家共识(2021版)》,旨在提供一个硬化注射治疗血管瘤的诊疗规范。&nbsp;</span></p>, tagList=[TagDto(tagId=20007, tagName=血管瘤)], categoryList=[CategoryDto(categoryId=23, categoryName=普通外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=92, categoryName=血管外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=20007, guiderKeyword=血管瘤, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2136, appHits=143, showAppHits=0, pcHits=369, showPcHits=1993, likes=2, shares=12, comments=3, approvalStatus=1, publishedTime=Mon Oct 25 16:24:48 CST 2021, publishedTimeString=2021-08-25, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=dajiong, createdTime=Mon Oct 25 16:11:27 CST 2021, updatedBy=6415643, updatedName=凯晨, updatedTime=Sat Jan 06 01:01:24 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=硬化注射治疗血管瘤专家共识.pdf)])
硬化注射治疗血管瘤专家共识.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1218773, encodeId=4fd71218e73b2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=WIRIOY8tZHCgMB81S37NzQ&s=100&t=1555990237, createdBy=89e15252657, createdName=冯云霞, createdTime=Wed May 11 16:25:36 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201945, encodeId=92991201945cc, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0af5475963, createdName=ms9000001115066421, createdTime=Sat Mar 12 11:09:16 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201069, encodeId=d023120106951, content=点赞 很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0af5475963, createdName=ms9000001115066421, createdTime=Wed Mar 09 22:11:21 CST 2022, time=2022-03-09, status=1, ipAttribution=)]
    2022-05-11 冯云霞

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1218773, encodeId=4fd71218e73b2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=WIRIOY8tZHCgMB81S37NzQ&s=100&t=1555990237, createdBy=89e15252657, createdName=冯云霞, createdTime=Wed May 11 16:25:36 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201945, encodeId=92991201945cc, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0af5475963, createdName=ms9000001115066421, createdTime=Sat Mar 12 11:09:16 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201069, encodeId=d023120106951, content=点赞 很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0af5475963, createdName=ms9000001115066421, createdTime=Wed Mar 09 22:11:21 CST 2022, time=2022-03-09, status=1, ipAttribution=)]
    2022-03-12 ms9000001115066421

    很实用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1218773, encodeId=4fd71218e73b2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=WIRIOY8tZHCgMB81S37NzQ&s=100&t=1555990237, createdBy=89e15252657, createdName=冯云霞, createdTime=Wed May 11 16:25:36 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201945, encodeId=92991201945cc, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0af5475963, createdName=ms9000001115066421, createdTime=Sat Mar 12 11:09:16 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201069, encodeId=d023120106951, content=点赞 很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0af5475963, createdName=ms9000001115066421, createdTime=Wed Mar 09 22:11:21 CST 2022, time=2022-03-09, status=1, ipAttribution=)]
    2022-03-09 ms9000001115066421

    点赞 很实用

    0